In the pool of glycemic control trials, 1,229 (30%) patients treated with semaglutide tablets were 65 years of age and over and 199 (5%) patients treated with semaglutide tablets were 75 years of age and over [see Clinical Studies (14)]
They are expected to report their findings later this year, with possible FDA approval in late 2026 or 2027
It is important to distinguish gallbladder-related pain from the common gastrointestinal side effects of semaglutide
Its primary goal is to stabilize blood sugar levels and reduce cardiovascular risk
At the end of the 52 weeks, the participants who took 50 mg of oral semaglutide had lost, on average, 17.5 pounds
During these shortages, compounding pharmacies started selling compounded semaglutide to fill the gap